SUBSCRIBE
SUBSCRIBE
News   Business

Vetoquinol Earnings for 2007 Attest to Strength of Business Growth Model

March 18, 2008 | 
1 min read

LURE, France--(BUSINESS WIRE)--Regulatory News: The Vétoquinol (Paris:VETO) board of directors, meeting on February 22, 2008, reviewed the group’s business in 2007 and approved the related financial statements

Earnings Europe
MORE ON THIS TOPIC
Pictured: Eli Lilly Campus in San Diego
Drug shortages
FDA Still Undecided About Shortage Status of Lilly’s Tirzepatide
November 22, 2024
 · 
2 min read
 · 
Tristan Manalac
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & Acquisitions
Novartis CEO Promises More Deals of Up to $5B, With an Eye for Early Science
November 21, 2024
 · 
2 min read
 · 
Annalee Armstrong
Business
51%: The Untapped Market
November 21, 2024
 · 
1 min read
 · 
Lori Ellis
Novartis' office building in Marburg, Germany
Mergers & acquisitions
Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market Opportunity by 2030
November 21, 2024
 · 
2 min read
 · 
Tristan Manalac